PHASE 1 TO 4

Phase 1 to 4 is managed by Poul Strange MD, PHD, who following academia has 15 years of pharmaceutical industry experience in positions ranging from drug discovery in the laboratories through pharmacology, clinical pharmacology, clinical development, and medical affairs, as well as three years of experience as an independent consultant to the biotech, device and pharmaceutical industries. Therapeutic area experience spans metabolism, cardiovascular disease, thrombosis, immunology supplemented with some oncology and neuroscience. Regulatory experience covers small molecules, biologics and devices... Based on intricate understanding of the specific company and already developed data Phase 1 to 4 provides advice for project portfolio, clinical development and medical affairs strategy for the biotech, device and pharmaceutical industries.

Also known as: Phase 1 to 4, LLC

Primary location: Princeton Junction United States